Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Levofloxacin

Levofloxacin
In stock
250mg · 500mg · 750mg
from 29,04 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
34,85 £29,04 £
0,97 £ per tablet

In brief

  • Levofloxacin is a prescription‑only medicine (POM) in the UK.
  • Levofloxacin is used to treat respiratory, urinary and skin/soft‑tissue infections (eg community‑acquired pneumonia, complicated urinary tract infections, pyelonephritis, sinusitis, prostatitis); it is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication.
  • Usual adult dosage is commonly 500 mg once daily (up to 500 mg twice daily depending on the indication): 500 mg OD for sinusitis/bronchitis/pyelonephritis, prostatitis 500 mg OD for 28 days; adjust for renal impairment.
  • Forms and administration: tablets (250/500 mg), intravenous infusion (500 mg/100 mL) and eye drops (0.5%); administered orally, intravenously or topically for eye infections.
  • Onset time: antibacterial activity begins within hours of dosing; many patients notice clinical improvement within 24–48 hours, although this depends on the infection and its severity.
  • Duration of action: effective drug concentrations are maintained for about 24 hours (half‑life roughly 6–8 hours), which is why once‑daily dosing is used; total treatment duration depends on the indication (typically 5–28 days).
  • Alcohol warning: avoid excessive alcohol while taking levofloxacin, as alcohol can increase dizziness, impair recovery and worsen certain side effects.
  • The most common side effects are gastrointestinal upset (nausea, diarrhoea) and headache; important serious risks include tendonitis/tendon rupture, CNS effects (eg seizures, confusion), QT prolongation and photosensitivity.
  • Would you like to try levofloxacin without a prescription?

Basic levofloxacin information

  • INN (international nonproprietary name): Levofloxacin.
  • Brand names available in the United Kingdom: Tavanic and multiple generics.
  • ATC code: J01MA12.
  • Forms and dosages: Tablets 250 mg, 500 mg; IV infusion 500 mg/100 mL; eye drops 0.5%.
  • Manufacturers in the United Kingdom: Sanofi (Tavanic); generics from several manufacturers.
  • OTC / Rx classification: Prescription-only medicine (POM).

Critical warnings and restrictions (safety first)

High‑risk groups (elderly, pregnancy, chronic illness)

Who should not be prescribed levofloxacin without clinician review?

  • Known allergy to levofloxacin or other quinolones, or prior quinolone‑related tendon disorder — absolute contraindication.
  • Children and adolescents, unless a specialist decides — growth‑cartilage risk applies.
  • Pregnancy or breastfeeding — generally avoided unless benefit clearly outweighs risk.
  • Existing seizure disorder, known QT prolongation, electrolyte imbalance, or severe renal impairment — dose adjustment or avoidance may be required.

Prescriber checklist before issuing a prescription:

  • Confirm absence of quinolone allergy and prior tendon reactions.
  • Check age and confirm specialist approval for paediatric cases.
  • Verify pregnancy and breastfeeding status.
  • Review ECG history, seizure history and current electrolyte results if available.
  • Assess renal function and calculate creatinine clearance for dosing.

Interaction with activities (driving, workplace safety under UK law)

Levofloxacin can cause dizziness, visual disturbance, insomnia and other central nervous system effects.

If these symptoms occur, patients must not drive or operate machinery until they have fully resolved.

Record any counselling about driving and safety in the patient counselling notes.

Report serious adverse events via the MHRA Yellow Card scheme.

Patient advice checklist:

  • Avoid driving or using machinery if you feel dizzy, faint, confused, or have visual changes.
  • Avoid heavy manual work or tasks requiring balance until symptom‑free.
  • Stop the medicine and seek urgent advice for seizures, fainting, or sudden severe dizziness.
  • Report suspected serious side effects using the Yellow Card or discuss with your GP or pharmacist.

Q&A — “Can I drive after taking it in the UK?”

Short answer: Only if you feel safe to do so and are free of neurological side effects.

If you experience dizziness, visual changes, fainting, seizures or new confusion while taking levofloxacin, do not drive and seek medical advice promptly.

A single brief episode that resolves normally does not usually require notifying the DVLA, but long‑term or recurring neurological problems should be discussed with your GP and may need formal assessment.

If a side effect affects your ability to control a vehicle, stop driving immediately and contact your prescriber or NHS 111 for next steps.

Document any episode in your medication record and consider reporting it via the MHRA Yellow Card scheme if it is severe or unexpected.

Usage basics

INN, brand names available in the UK

Patients often ask which name will appear on the label.

INN Common brand names Typical manufacturer
Levofloxacin Tavanic Sanofi
Levofloxacin Generic levofloxacin Multiple manufacturers

Legal classification (POM, P, GSL)

Levofloxacin is a prescription‑only medicine (POM) in the UK.

Pharmacists must confirm a valid prescription before supply and provide appropriate counselling, checking interactions and renal dosing.

Electronic prescriptions and NHS e‑prescribing systems are commonly used for POM handling.

Verification checklist for pharmacists:

  • Confirm valid POM and prescriber details.
  • Check patient identity and medication history for interactions.
  • Confirm pregnancy/breastfeeding status where appropriate.
  • Provide counselling on dose, interactions and side effects.

Dosing guide

Standard regimens (NHS guidelines)

Below are typical adult regimens used in practice; local formularies and NICE guidance may favour alternatives for some infections.

Indication Typical dose Usual duration
Acute sinusitis 500 mg once daily 10–14 days
Community-acquired pneumonia 500 mg once or twice daily 7–14 days
Exacerbation of chronic bronchitis 500 mg once daily 7–10 days
Complicated UTI 500 mg once daily 7–14 days
Pyelonephritis 500 mg once daily 7–10 days
Skin/soft tissue infection 500 mg once or twice daily 7–14 days
Chronic bacterial prostatitis 500 mg once daily 28 days

Adjustments for comorbidities

Renal function is the main driver of dose adjustment for levofloxacin.

Use the following mini algorithm to guide dosing when creatinine clearance is known.

  • If CrCl 20–50 mL/min: give 500 mg as the initial dose, then 250 mg once daily.
  • If CrCl 10–19 mL/min: give 500 mg as the initial dose, then 125 mg once daily.
  • If CrCl <10 mL/min: give 500 mg as the initial dose, then 125 mg every 48 hours.
  • Children: not routinely indicated; specialist dosing only for severe cases.
  • Elderly: adjust based on renal function rather than age alone.

Q&A — “What if I miss a dose?”

Take the missed dose as soon as you remember unless it is almost time for the next scheduled dose.

Do not double up or take extra tablets to make up for missed doses as this can increase side‑effect risk.

If several doses are missed or you are unsure, phone your prescriber or pharmacist for specific advice rather than guessing.

Finish the prescribed course unless a clinician advises otherwise, because stopping early can allow the infection to persist and encourage resistance.

If you experience unusual symptoms after taking an extra dose by mistake, seek urgent medical attention, particularly if you develop palpitations, severe dizziness or neurological symptoms.

Interaction chart

Food and drinks

Some common food and drink interactions reduce absorption or increase side effects.

  • Divalent and trivalent cations such as calcium, magnesium, iron and aluminium reduce oral absorption; separate doses by 2–4 hours.
  • Dairy and calcium‑fortified drinks can interfere with absorption; take levofloxacin with plain water rather than immediately with milk or fortified drinks.
  • Alcohol is not directly contraindicated but may increase the risk of CNS effects such as dizziness or drowsiness; advise caution.

Patient leaflet — what to avoid:

  • Do not take antacids, iron supplements or calcium tablets within two to four hours of levofloxacin.
  • Avoid alcohol if you experience dizziness, drowsiness or poor coordination while on treatment.

Common drug conflicts

Drug Risk Action
Warfarin and other anticoagulants Altered INR and bleeding risk Monitor INR closely and adjust dose as needed.
QT‑prolonging medicines (amiodarone, sotalol, certain antipsychotics) Additive QT prolongation and arrhythmia risk Avoid combination where possible and check ECG if necessary.
NSAIDs May increase CNS stimulation and seizure risk Use with caution; consider alternatives for pain management.
Antacids / iron / sucralfate Reduced oral absorption of levofloxacin Separate dosing by 2–4 hours to preserve efficacy.

Pharmacists should check medicine records and refer to the prescriber if potentially interacting medicines are present.

Legal status and availability in the UK

In our online pharmacy, levofloxacin is available without a prescription, with discreet delivery to the United Kingdom in 5‑14 days.

Mechanism and pharmacology

Simplified explanation

Levofloxacin is a fluoroquinolone antibacterial with ATC code J01MA12.

It is bactericidal because it inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and repair.

This mechanism makes levofloxacin effective against a broad range of Gram‑negative organisms and some Gram‑positive bacteria.

Clinical terms

Key pharmacokinetic points are straightforward for counselling.

  • Bioavailability: levofloxacin has good oral bioavailability comparable to IV dosing.
  • Renal clearance: the drug is predominantly eliminated by the kidneys, hence renal dose adjustment.
  • Forms: tablets 250/500 mg, IV infusion and eye drops.

Indications and off‑label uses

MHRA‑approved uses

The following indications reflect licensed UK uses and typical dosing.

Indication Typical dose Usual duration
Community-acquired pneumonia 500 mg once or twice daily 7–14 days
Acute sinusitis 500 mg once daily 10–14 days
Complicated UTI / pyelonephritis 500 mg once daily 7–14 days
Skin and soft tissue infections 500 mg once or twice daily 7–14 days
Chronic bacterial prostatitis 500 mg once daily 28 days

Duration and dose may vary by severity and local guideline recommendation.

Off‑label practices in NHS and private care

Off‑label uses are limited and require specialist justification and documentation.

  • Selected paediatric use in severe systemic infections under specialist care.
  • Cultured, resistant organisms where alternative agents are unsuitable.
  • Off‑label prescribing should be documented with a clear rationale and informed consent.

Alternatives matrix

NHS prescribing alternatives (comparison table)

Agent Typical indication Key advantages Key disadvantages
Ciprofloxacin Gram‑negative UTIs Strong Gram‑negative activity Same class risks: tendons, CNS effects
Moxifloxacin Respiratory infections Good respiratory coverage Greater QT risk; poorer urinary excretion
Co-amoxiclav Chest and ENT infections Established first‑line for many infections Less active against resistant Gram‑negatives
Doxycycline Atypical chest infections Useful where atypical pathogens are suspected Not ideal for severe Gram‑negative sepsis

Prescriber checklist for choosing an alternative:

  • Consider likely pathogen and local susceptibility.
  • Check patient comorbidities including pregnancy status and tendon history.
  • Review interaction profile and renal function before selecting an agent.

Pros and cons checklist

  • Choose an alternative in pregnancy, prior tendon reactions, seizure disorders or high QT risk.
  • Prefer narrower spectrum options where possible to support stewardship.
  • Document the clinical reason when a fluoroquinolone is used as second‑line or for resistant organisms.

Common questions (patient‑facing mini FAQs)

  • Will levofloxacin cause tendon rupture? Rare but serious; report any tendon pain, swelling or difficulty using a limb immediately and stop activity.
  • Is it safe in pregnancy or breastfeeding? Generally avoided; only used if essential after a benefit/risk discussion with your prescriber.
  • How soon will I feel better? Many patients see improvement within 48–72 hours for susceptible infections; complete the full course unless advised otherwise.
  • What to do with missed doses or overdose? Missed: take when remembered but do not double up; Overdose: seek emergency care because of risks including QT changes and seizures.

Registration and regulation

MHRA approval process

Levofloxacin is licensed in the UK as a prescription-only medicine, and the MHRA issues safety updates when new data emerge.

Clinicians and pharmacists should consult MHRA guidance and report adverse reactions using the Yellow Card scheme.

NHS prescribing framework

Antimicrobial stewardship requires prescribers to follow local Trust formularies and NICE guidance where applicable.

Record the indication on the prescription and review therapy at 48–72 hours to stop or de‑escalate where appropriate.

Pharmacist/prescriber checklist for safe prescribing:

  • Ensure the indication is correct and documented on the prescription.
  • Confirm dose and renal adjustment where required.
  • Check for interacting medicines and provide counselling on safety and Yellow Card reporting.

Storage and handling

UK household storage (cold/damp climate)

Store tablets at 15–30°C and avoid moisture and strong light.

Do not refrigerate solid oral tablets and keep the medicine in its original packaging while in household storage.

  • Keep medicines out of reach and sight of children.
  • Avoid storing tablets in bathrooms or near sinks where humidity is high.
  • Follow product label instructions for IV and eye-drop preparations, which may differ.

Guidance from NHS and pharmacists

Return unused or expired medicines to your pharmacy for safe disposal.

Hospital IV stock should follow the Trust’s pharmaceutical SOPs for storage and cold chain as required.

  • Expiry: do not use past the printed date on the packaging.
  • Batch: useful to report when reporting adverse events.
  • Storage temp: observe label instructions for specific formulations.

Guidelines for proper use (patient safety emphasis)

UK pharmacist counselling style

Counselling is brief, clear and focused on safety, interactions and red flags.

  • Confirm the indication and authenticity of the prescription.
  • Explain the dosing schedule and the need to separate from antacids, iron and calcium supplements.
  • Warn about tendon pain, central nervous system effects and photosensitivity and advise immediate action if these occur.
  • Advise on driving and machinery if side effects occur and provide Yellow Card reporting details.

NHS patient safety advice

Encourage patients to complete the prescribed course unless told otherwise, and to seek urgent review for red flags.

Red flags include severe allergic reaction, sudden tendon pain or swelling, chest pain or palpitations and new seizure activity.

Provide clear contact options: GP, NHS 111, or emergency services depending on symptom severity.

Delivery across the United Kingdom

City Region Delivery time
London England 9–21 days
Birmingham England 9–21 days
Manchester England 9–21 days
Glasgow Scotland 9–21 days
Leeds England 9–21 days
Liverpool England 9–21 days
Bristol England 9–21 days
Sheffield England 9–21 days
Edinburgh Scotland 9–21 days
Leicester England 9–21 days
Coventry England 9–21 days
Kingston Upon Hull England 9–21 days
Bradford England 9–21 days
Belfast Northern Ireland 9–21 days
Cardiff Wales 9–21 days

Related products